Corteva (NYSE:CTVA) Rating Increased to Hold at KeyCorp

Corteva (NYSE:CTVA) was upgraded by research analysts at KeyCorp to a “hold” rating in a research report issued to clients and investors on Thursday, Zacks reports. KeyCorp also issued estimates for Corteva’s Q3 2026 earnings at ($0.33) EPS, Q4 2026 earnings at $0.31 EPS, FY2027 earnings at $4.00 EPS and FY2028 earnings at $4.20 EPS.

A number of other analysts have also weighed in on CTVA. JPMorgan Chase & Co. upped their price target on shares of Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Mizuho lifted their price target on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. Oppenheimer boosted their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Weiss Ratings downgraded Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Finally, Bank of America upped their price target on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, Corteva has an average rating of “Moderate Buy” and a consensus target price of $91.50.

Corteva Trading Down 0.4%

Shares of NYSE CTVA opened at $84.43 on Thursday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The company has a market cap of $56.33 billion, a price-to-earnings ratio of 55.92, a price-to-earnings-growth ratio of 2.60 and a beta of 0.57. Corteva has a 12-month low of $60.53 and a 12-month high of $90.97. The stock’s 50 day simple moving average is $83.54 and its 200 day simple moving average is $81.31.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts expect that Corteva will post 3.72 EPS for the current year.

Institutional Trading of Corteva

Several large investors have recently made changes to their positions in the stock. Brighton Jones LLC boosted its holdings in shares of Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after buying an additional 11,760 shares during the period. Woodline Partners LP raised its holdings in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after acquiring an additional 16,644 shares during the period. EverSource Wealth Advisors LLC lifted its position in Corteva by 62.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after acquiring an additional 980 shares during the last quarter. Cresset Asset Management LLC lifted its position in Corteva by 2.6% during the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after acquiring an additional 181 shares during the last quarter. Finally, Jump Financial LLC bought a new stake in Corteva during the second quarter valued at about $1,464,000. Institutional investors own 81.54% of the company’s stock.

More Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Long-term earnings outlook improved: KeyCorp projects $4.00 in fiscal 2027 EPS and $4.20 in fiscal 2028 EPS, above the current-year consensus estimate of $3.72. The forecasts suggest expectations for continued earnings growth beyond 2026.
• Positive Sentiment: New crop-protection venture: Corteva and Globachem agreed to form a joint venture focused on developing and commercializing formulated crop-protection products in high-growth markets. The partnership could expand Corteva’s product pipeline and commercial reach, although financial details were not disclosed. Corteva and Globachem joint venture announcement
• Neutral Sentiment: Near-term estimates are mixed: KeyCorp expects a $0.33 per-share loss in the third quarter of 2026 but $0.31 in EPS for the fourth quarter. The estimates are broadly consistent with Corteva’s seasonal earnings pattern and do not change the current full-year consensus of $3.72 EPS.
• Negative Sentiment: PFAS settlement adds a legal cost: Corteva, DuPont and Chemours agreed to pay $455 million to North Carolina and 11 local entities over contamination claims associated with the Fayetteville Works plant and historical discharges. The settlement removes some litigation uncertainty but may pressure cash flow and reinforces environmental-liability concerns. Reuters PFAS settlement report

Corteva Company Profile

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.